Characterization of BRCA1 and BRCA2 genetic variants in a cohort of Bahraini breast cancer patients using next-generation sequencing
- PMID: 31131559
- PMCID: PMC6625152
- DOI: 10.1002/mgg3.771
Characterization of BRCA1 and BRCA2 genetic variants in a cohort of Bahraini breast cancer patients using next-generation sequencing
Abstract
Background: Breast cancer is the most common malignancy in women worldwide. About 5%-10% are due to hereditary predisposition. The contribution of BRCA1/2 mutations to familial breast cancer in Bahrain has not been explored. The objective of this study was to investigate the spectrum of BRCA1/2 genetic variants and estimate their frequencies in familial breast cancer. We also aim to test the efficiency of the next-generation sequencing (NGS) as a powerful tool for detecting genetic variation within BRCA1/2 genes.
Methods: Twenty-five unrelated female patients diagnosed with familial breast cancer were screened for BRCA1/2 variants. All targeted coding exons and exon-intron boundaries of BRCA1/2 genes were amplified with 167 pairs of primers by NGS.
Results: We have identified two deleterious BRCA1/2 variants in two patients, one in BRCA1 gene (c.4850C>A) and other in BRCA2 gene (c.67+2T>C). In addition to the deleterious variants, we identified 24 distinct missense variants of uncertain significance, 10 of them are seen to confer minor but cumulatively significant risk of breast cancer.
Conclusion: Our data suggest that BRCA1/2 variants may contribute to the pathogenesis of familial breast cancer in Bahrain. It also shows that NGS is useful tool for screening BRCA1/2 genetic variants of probands and unaffected relatives.
Keywords: BRCA1/2; Bahrain; breast cancer; next-generation sequencing; variants.
© 2019 RCSI BAHRAIN. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.
Conflict of interest statement
The authors declare that there is no conflict of interest regarding the publication of this article.
References
-
- Bu, R. , Siraj, A. K. , Al‐Obaisi, K. A. , Beg, S. , Al Hazmi, M. , Ajarim, D. , … Al‐Kuraya, K. S. (2016). Identification of novel BRCA founder mutations in Middle Eastern breast cancer patients using capture and Sanger sequencing analysis. International Journal of Cancer, 139(5), 1091–1097. 10.1002/ijc.30143 - DOI - PMC - PubMed
-
- Bujassoum, S. M. , Bugrein, H. A. , & Al‐Sulaiman, R. (2017). Genotype and phenotype correlation of breast cancer in BRCA mutation carriers and non‐carriers. Journal of Cancer Science & Therapy, 9(2), 358–362. 10.4172/1948-5956.1000442 - DOI
-
- Carraro, D. M. , Koike Folgueira, M. A. A. , Garcia Lisboa, B. C. , Ribeiro Olivieri, E. H. , Vitorino Krepischi, A. C. , de Carvalho, A. F. , … Brentani, M. M. (2013). Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: A portrait of early‐onset breast cancer in Brazil. PLoS ONE, 8(3), e57581 10.1371/journal.pone.0057581 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous